Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]KDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
03 Sep 2025
Reply
17 Jul 2025
Reply
17 Feb 2025
Reply
25 Jan 2025
Reply
29 Aug 2024
Reply
07 Aug 2024
Reply
07 Jul 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
25
PharmaCompass offers a list of Rimegepant Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Rimegepant Sulfate manufacturer or Rimegepant Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rimegepant Sulfate manufacturer or Rimegepant Sulfate supplier.
A Rimegepant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rimegepant, including repackagers and relabelers. The FDA regulates Rimegepant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rimegepant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rimegepant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Rimegepant supplier is an individual or a company that provides Rimegepant active pharmaceutical ingredient (API) or Rimegepant finished formulations upon request. The Rimegepant suppliers may include Rimegepant API manufacturers, exporters, distributors and traders.
click here to find a list of Rimegepant suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Rimegepant DMF (Drug Master File) is a document detailing the whole manufacturing process of Rimegepant active pharmaceutical ingredient (API) in detail. Different forms of Rimegepant DMFs exist exist since differing nations have different regulations, such as Rimegepant USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rimegepant DMF submitted to regulatory agencies in the US is known as a USDMF. Rimegepant USDMF includes data on Rimegepant's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rimegepant USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rimegepant suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Rimegepant Drug Master File in Korea (Rimegepant KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Rimegepant. The MFDS reviews the Rimegepant KDMF as part of the drug registration process and uses the information provided in the Rimegepant KDMF to evaluate the safety and efficacy of the drug.
After submitting a Rimegepant KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Rimegepant API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Rimegepant suppliers with KDMF on PharmaCompass.
A Rimegepant written confirmation (Rimegepant WC) is an official document issued by a regulatory agency to a Rimegepant manufacturer, verifying that the manufacturing facility of a Rimegepant active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Rimegepant APIs or Rimegepant finished pharmaceutical products to another nation, regulatory agencies frequently require a Rimegepant WC (written confirmation) as part of the regulatory process.
click here to find a list of Rimegepant suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rimegepant as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rimegepant API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rimegepant as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rimegepant and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rimegepant NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rimegepant suppliers with NDC on PharmaCompass.
Rimegepant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rimegepant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Rimegepant GMP manufacturer or Rimegepant GMP API supplier for your needs.
A Rimegepant CoA (Certificate of Analysis) is a formal document that attests to Rimegepant's compliance with Rimegepant specifications and serves as a tool for batch-level quality control.
Rimegepant CoA mostly includes findings from lab analyses of a specific batch. For each Rimegepant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rimegepant may be tested according to a variety of international standards, such as European Pharmacopoeia (Rimegepant EP), Rimegepant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rimegepant USP).
Comment (1)
